Associations between "Cancer Risk", "Inflammation" and "Metabolic Syndrome": A Scoping Review

被引:33
作者
Vitale, Elsa [1 ]
Rizzo, Alessandro [2 ]
Santa, Kazuki [3 ]
Jirillo, Emilio [4 ]
机构
[1] IRCCS, Sci Directorate, Ist Tumori Giovanni Paolo II, Viale Orazio Flacco 65, I-70124 Bari, Italy
[2] IRCCS, Med Oncol, Ist Tumori Giovanni Paolo II, Viale Orazio Flacco 65, I-70124 Bari, Italy
[3] Juntendo Univ, Fac Med Sci, 6-8-1 Hinode, Urayasu, Chiba 2790013, Japan
[4] Univ Bari, Scuola Med, I-70121 Bari, Italy
来源
BIOLOGY-BASEL | 2024年 / 13卷 / 05期
关键词
cancer risk; inflammation; metabolic syndrome; oncogenesis; oxidative stress; FATTY LIVER-DISEASE; PROSTATE-CANCER; INSULIN-RESISTANCE; DIABETES-MELLITUS; COLORECTAL-CANCER; OXIDATIVE STRESS; OBESITY; BREAST; EPIDEMIOLOGY; MECHANISMS;
D O I
10.3390/biology13050352
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary Individuals with metabolic syndrome exhibit simultaneously pro-thrombotic and a pro-inflammatory conditions which more probably can lead to cardiovascular disease progression, type 2 diabetes mellitus, and some types of cancer. The present scoping review is aimed at highlighting any relations between cancer risk, inflammation, and metabolic syndrome. A total of 20 manuscripts were identified and, among them, we identified some associations with breast cancer, colorectal cancer, esophageal adenocarcinoma, hepatocellular carcinoma (HCC), and cancer in general. Therefore, it could be deducted that cancer and its related progression may also depend on a latent chronic inflammatory condition associated with other concomitant conditions, including type 2 diabetes mellitus, metabolic syndrome, and obesity. Therefore, prevention may potentially help individuals to protect themselves from cancer.Abstract Background: Individuals with metabolic syndrome exhibit simultaneously pro-thrombotic and pro-inflammatory conditions which more probably can lead to cardiovascular diseases progression, type 2 diabetes mellitus, and some types of cancer. The present scoping review is aimed at highlighting the association between cancer risk, inflammation, and metabolic syndrome. Methods: A search strategy was performed, mixing keywords and MeSH terms, such as "Cancer Risk", "Inflammation", "Metabolic Syndrome", "Oncogenesis", and "Oxidative Stress", and matching them through Boolean operators. A total of 20 manuscripts were screened for the present study. Among the selected papers, we identified some associations with breast cancer, colorectal cancer, esophageal adenocarcinoma, hepatocellular carcinoma (HCC), and cancer in general. Conclusions: Cancer and its related progression may also depend also on a latent chronic inflammatory condition associated with other concomitant conditions, including type 2 diabetes mellitus, metabolic syndrome, and obesity. Therefore, prevention may potentially help individuals to protect themselves from cancer.
引用
收藏
页数:20
相关论文
共 99 条
[51]   Peroxisome proliferators-activated receptor gamma polymorphisms and colorectal cancer risk [J].
Liang, Xuemin ;
Fan, Xiaohua ;
Tan, Kanglian ;
Zhang, Li ;
Jian, Lisi ;
Yu, Linchong .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 :S306-S310
[52]  
Liao SC, 2011, ASIAN PAC J CANCER P, V12, P1061
[53]   Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer [J].
Liu, Qi ;
Jiang, Jianwu ;
Zhang, Xiefu ;
Zhang, Meixiang ;
Fu, Yang .
FRONTIERS IN ONCOLOGY, 2021, 11
[54]   Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study [J].
Mantovani, Alessandro ;
Taverna, Antonio ;
Cappelli, Davide ;
Beatrice, Giorgia ;
Csermely, Alessandro ;
Sani, Elena ;
Byrne, Christopher D. ;
Targher, Giovanni .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
[55]   Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis [J].
Marshall, Erin A. ;
Ng, Kevin W. ;
Kung, Sonia H. Y. ;
Conway, Emma M. ;
Martinez, Victor D. ;
Halvorsen, Elizabeth C. ;
Rowbotham, David A. ;
Vucic, Emily A. ;
Plumb, Adam W. ;
Becker-Santos, Daiana D. ;
Enfield, Katey S. S. ;
Kennett, Jennifer Y. ;
Bennewith, Kevin L. ;
Lockwood, William W. ;
Lam, Stephen ;
English, John C. ;
Abraham, Ninan ;
Lam, Wan L. .
MOLECULAR CANCER, 2016, 15
[56]   Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer [J].
Mates, Jose M. ;
Di Paola, Floriana J. ;
Campos-Sandoval, Jose A. ;
Mazurek, Sybille ;
Marquez, Javier .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2020, 98 :34-43
[57]   Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management [J].
McPherson, Stuart ;
Hardy, Tim ;
Henderson, Elsbeth ;
Burt, Alastair D. ;
Day, Christopher P. ;
Anstee, Quentin M. .
JOURNAL OF HEPATOLOGY, 2015, 62 (05) :1148-1155
[58]  
Melnyk B.M., 2015, Evidence-based practice in nursing healthcare: A guide to best practice, V3rd, P10
[59]   Metabolic syndrome: A clinical and molecular perspective [J].
Moller, DE ;
Kaufman, KD .
ANNUAL REVIEW OF MEDICINE, 2005, 56 :45-+
[60]   Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH [J].
Montesi, Luca ;
Mazzotti, Arianna ;
Moscatiello, Simona ;
Forlani, Gabriele ;
Marchesini, Giulio .
HEPATOLOGY INTERNATIONAL, 2013, 7 :S814-S822